Concepedia

Publication | Closed Access

Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial

DOI

714

Citations

22

References

2018

Year

Richard E. Pratley, Vanita R. Aroda, Ildiko Lingvay, J Lüdemann, Camilla Andreassen, Andrea Navarria, Adie Viljoen
The Lancet Diabetes & Endocrinology

References

YearCitations

Page 1